retatrutide results women 1 month Reta update : r/Retatrutide The next Ozempic? New weight-loss

(MUSIC BRIDGE) Trina Wilcox: Welcome to the Live Yes

Another triple agonist candidate, Hanmis efocipegtrutide (HM15211), is in a phase 1 trial for weight loss and in a phase 1b/2a for nonalcoholic fatty liver disease (NAFLD)

W grupie kontrolnej zwierzt stwierdzono wystpowanie kamieni moczowych i przetok pcherzowo-pochwow

Common Side Effects GLP-1 medications often cause gastrointestinal (GI) issues , especially when starting treatment: 1

American Society of Anesthesiologists+2PubMed+2 A 2025 cohort study did not find a major increase in postoperative aspiration pneumonia among GLP-1 users overall, which is reassuring, but care still needs to be tailored to the individual